Oxford leads the race for a vaccine

The University of Oxford’s ChAdOx1 nCoV-19 is the world-leading vaccine candidate, according to the Chief Scientist of the World Health Organisation.  Phase 1 trial results released earlier today suggest that the vaccine is “safe, tolerated and immunogenic”. It may also offer “double protection” against the deadly virus. The British-Swedish pharmaceutical giant AstraZeneza is helping developing […]

Continue Reading